Notice of Half-Year Financial Results
Faron Pharmaceuticals Ltd. (“Faron” or the “Company”) Faron Pharmaceuticals Notice of Half-Year Financial Results Company Announcement, August 4, 2023 TURKU, Finland / BOSTON, Massachusetts – Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, will report its unaudited half-year financial results for the six months ended June 30, 2023, on Tuesday, August 29, 2023. A live virtual briefing and Q&A session for investors, analysts and media will be